[{"address1": "7171 Frederick-Banting, Building 2", "address2": "Suite 270 St-Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "857-412-7018", "website": "https://www.reparerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 129, "companyOfficers": [{"maxAge": 1, "name": "Dr. Daniel  Durocher Ph.D.", "title": "Co-Founder", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Sicheri Ph.D.", "title": "Co-Founder", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Agnel  Sfeir Ph.D.", "title": "Co-Founder", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sandra  Alves", "title": "Chief Accounting Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Zinda Ph.D.", "age": 53, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 641532, "exercisedValue": 0, "unexercisedValue": 1476505}, {"maxAge": 1, "name": "Mr. Daniel  Belanger", "title": "Executive Vice President of Human Resource", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip  Herman", "age": 44, "title": "Executive VP, Chief Commercial & Portfolio Development Officer", "yearBorn": 1980, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.15, "open": 1.15, "dayLow": 1.15, "dayHigh": 1.32, "regularMarketPreviousClose": 1.15, "regularMarketOpen": 1.15, "regularMarketDayLow": 1.15, "regularMarketDayHigh": 1.32, "payoutRatio": 0.0, "beta": 0.908, "forwardPE": -0.40404043, "volume": 840363, "regularMarketVolume": 828108, "averageVolume": 290290, "averageVolume10days": 606600, "averageDailyVolume10Day": 606600, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 51012844, "fiftyTwoWeekLow": 0.89, "fiftyTwoWeekHigh": 4.29, "priceToSalesTrailing12Months": 0.9539212, "fiftyDayAverage": 1.12848, "twoHundredDayAverage": 2.417195, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -99845152, "profitMargins": -1.5836501, "floatShares": 22476262, "sharesOutstanding": 42510700, "sharesShort": 795854, "sharesShortPriorMonth": 1059894, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0187, "heldPercentInsiders": 0.01005, "heldPercentInstitutions": 0.79987, "shortRatio": 3.63, "shortPercentOfFloat": 0.031, "impliedSharesOutstanding": 42510700, "bookValue": 3.555, "priceToBook": 0.33755276, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -84689000, "trailingEps": -2.0, "forwardEps": -2.97, "enterpriseToRevenue": -1.867, "enterpriseToEbitda": 1.107, "52WeekChange": -0.63190186, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 1.2, "targetHighPrice": 8.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 152791008, "totalCashPerShare": 3.594, "ebitda": -90223000, "totalDebt": 1933000, "quickRatio": 6.531, "currentRatio": 6.768, "totalRevenue": 53477000, "debtToEquity": 1.279, "revenuePerShare": 1.261, "returnOnAssets": -0.26760998, "returnOnEquity": -0.46633, "grossProfits": 40099000, "freeCashflow": -44043000, "operatingCashflow": -76445000, "revenueGrowth": -1.0, "grossMargins": 0.74984, "ebitdaMargins": -1.68714, "operatingMargins": -1.72306, "financialCurrency": "USD", "symbol": "RPTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1744933953, "regularMarketTime": 1744920000, "exchange": "NMS", "messageBoardId": "finmb_435208167", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 4.3478327, "regularMarketPrice": 1.2, "shortName": "Repare Therapeutics Inc.", "longName": "Repare Therapeutics Inc.", "averageDailyVolume3Month": 290290, "fiftyTwoWeekLowChange": 0.31000006, "fiftyTwoWeekLowChangePercent": 0.34831467, "fiftyTwoWeekRange": "0.89 - 4.29", "fiftyTwoWeekHighChange": -3.09, "fiftyTwoWeekHighChangePercent": -0.7202797, "fiftyTwoWeekChangePercent": -63.190186, "earningsTimestamp": 1741003500, "earningsTimestampStart": 1741003500, "earningsTimestampEnd": 1741003500, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.0, "epsForward": -2.97, "epsCurrentYear": -2.11, "priceEpsCurrentYear": -0.5687204, "fiftyDayAverageChange": 0.07152009, "fiftyDayAverageChangePercent": 0.063377365, "twoHundredDayAverageChange": -1.217195, "twoHundredDayAverageChangePercent": -0.5035568, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-19", "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1592573400000, "postMarketChangePercent": 0.125001, "postMarketPrice": 1.2015, "postMarketChange": 0.00150001, "regularMarketChange": 0.05000007, "regularMarketDayRange": "1.15 - 1.32", "fullExchangeName": "NasdaqGS", "displayName": "Repare Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]